Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent, was found to have promising anti-tumor activity
Category: Systemic therapy
Yescarta for cancer treatment
Yescarta is a chimeric antigen receptor T cell CAR T therapy for the treatment of adult patients with relapsed or
